Perspectives of Families Working With Nunavut’s Foster Care System

The purpose of this report is to communicate the results of the data collected in phase two component three of the Child and Youth Mental Health Intervention, Research and Community Advocacy Project in Nunavut that assess the needs of foster parents engaged with the foster care system

Inunnguiniq Parenting Support Program for Nunavummiut: Evaluation Report

The purpose of this project is to research, develop, implement and evaluate child and youth mental health and wellness initiatives in Nunavut that focus on Northern and community-based ways of understanding and knowing about healthy children and youth

EXPLORING THE PERSPECTIVES OF FRONTLINE MENTAL HEALTH WORKERS IN NUNAVUT

The purpose of this report is to communicate the results of the data collected for the Child and Youth Mental Health Intervention, Research and Community Advocacy Project in Nunavut at the Qaujigiartiit Health Research Centre

ATII GAMESHOW, Healthy Living Intervention for School Children in Nunavut: Evaluation Report

The purpose of this project was to improve the ability of Inuit children to make healthy choices about food and activity and carry health knowledge forward with them into adolescence and adulthood; to improve health literacy in Inuktitut; to engage children in a fun, team-style health promotion game; to promote and evaluate a local intervention developed by young, motivated Inuit youth workers in Nunavut.; to hire and train youth to lead and implement and deliver the intervention

CLIMATE CHANGE AND HEALTH COMMUNITY PHOTOVOICE RESEARCH PROJECT

This project employed the photovoice technique in order to explore the impacts of climate change on health in Nunavut, from the perspectives of community members. This project provided participants with the opportunity to not only apply the skills learned during the workshop, but also contribute to a growing body of knowledge about the effects on climate change on the health of northerners

Robot Comedy Lab: experimenting with the social dynamics of live performance

Copyright © 2015 Katevas, Healey and Harris. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.This document is protected by copyright and was first published by Frontiers. All rights reserved. It is reproduced with permission.This work was funded by EPSRC (EP/G03723X/1) through the Media and Arts Technology Program, an RCUK Center for Doctoral Training

Organizational Assessment and Development Guide for Regional Associations

This publication was originally a product of The Regional Initiative, a 1992-1995special project cosponsored by the Council on Foundations and twenty-four of the nation's regional associations of grantmakers (RAGs). The purpose of the Initiative was to enhance the capacity of regional associations to meet their members' needs, by building both management and program effectiveness. The Initiative's long-term goal was to strengthen regional associations as agents of organized philanthropy in American life

Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy

BACKGROUND and AIMS: Hepatitis C virus (HCV) infection has been associated with intravenous (IV) immunoglobulin (Ig), and plasma donations used to prepare IV Ig are now screened to prevent transmission. Thirty-six patients from the United Kingdom received infusions from a batch of anti-HCV antibody-screened intravenous Ig (Gammagard; Baxter Healthcare Ltd., Thetford, Norfolk, England) that was associated with reports of acute hepatitis C outbreak in Europe. The aim of this study was to document the epidemiology of this outbreak. METHODS: Forty-six patients from the United Kingdom treated with Gammagard (34 exposed and 12 unexposed to the batch) returned epidemiological questionnaires. RESULTS: Eighty-two percent of the exposed patients (28 of 34) became positive for HCV RNA. Eighteen percent of the patients (6 of 34) who had infusions with this batch tested negative for HCV RNA, but 2 of the patients had abnormal liver function and subsequently seroconverted to anti-HCV antibody positive. Twenty-seven percent of the patients (9 of 34) developed jaundice, and 79% (27 of 34) had abnormal liver transferase levels. Virus isolates (n=21), including an isolate from the implicated batch, were genotype 1a and virtually identical by sequence analysis of the NS5 region, consistent with transmission from a single source. CONCLUSIONS: Hepatitis C infection can be transmitted by anti-HCV-screened IV Ig. Careful documentation of IV Ig batch numbers and regular biochemical monitoring is recommended for all IV Ig recipients